Nifty

:

17274.30

Sensex

:

58065.47

386.95 (2.29%)
1276.66 (2.25%)

Login

Nifty
Sensex

:
:

17274.30
58065.47

386.95 (2.29%)
1276.66 (2.25%)

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

44/99

BSE: 524494 | NSE: IPCALAB

Watchlist

NSE BSE

932.15

04-Oct-2022

Day's Open
Day's High
Day's Low
Previous Close

941.00
945.00
921.95
934.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

329783
3075.06
1228.35
831.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

23,717.54
32.92
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

23,868.12
0.43%
4.20

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.53
12.22
7.86

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.87
23.26
7.15

PAT CAGR (%)

10 Years
5 Years
3 Years

10.81
30.02
13.81

P:E (Median)

8 Years
5 Years
3 Years

32.35
30.76
28.00

P:BV (Average)

8 Years
5 Years
3 Years

4.19
4.59
5.27

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.59
18.88
18.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 1,469.28 1,478.60 -0.63% 1,168.45 1,040.92 12.25% 1,328.47 1,315.22 1.01% 1,423.84 1,297.77 9.71%
Expenses 1,211.83 1,084.62 11.73% 989.43 824.28 20.04% 1,016.95 966.39 5.23% 1,064.82 937.61 13.57%
EBITDA 257.45 393.98 -34.65% 179.02 216.64 -17.37% 311.52 348.83 -10.70% 359.02 360.16 -0.32%
EBIDTM 17.52% 26.65% 15.32% 20.81% 23.45% 26.52% 25.21% 27.75%
Other Income 18.81 13.61 38.21% 14.21 19.91 -28.63% 13.24 15.65 -15.40% 15.07 15.00 0.47%
Interest 6.79 1.26 438.89% 3.21 2.31 38.96% 1.27 1.56 -18.59% 1.47 1.81 -18.78%
Depreciation 53.41 49.96 6.91% 52.39 48.57 7.86% 51.25 47.66 7.53% 50.50 46.26 9.17%
PBT 216.06 356.37 -39.37% 137.63 185.67 -25.87% 272.24 315.26 -13.65% 322.12 327.09 -1.52%
Tax 72.24 71.65 0.82% 27.22 34.19 -20.39% 54.07 55.29 -2.21% 64.48 51.41 25.42%
PAT 143.82 284.72 -49.49% 110.41 151.48 -27.11% 218.17 259.97 -16.08% 257.64 275.68 -6.54%
PATM 9.79% 19.26% 9.45% 14.55% 16.42% 19.77% 18.09% 21.24%
EPS 5.67 11.22 -49.47% 4.35 5.97 -27.14% 8.60 10.25 -16.10% 10.16 10.87 -6.53%

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 1,585.74 1,565.79 1.27% 1,289.10 1,114.66 15.65% 1,430.47 1,409.83 1.46% 1,544.43 1,361.10 13.47%
Expenses 1,316.51 1,149.25 14.55% 1,069.77 885.75 20.78% 1,122.66 1,042.90 7.65% 1,178.85 1,000.91 17.78%
EBITDA 269.23 416.54 -35.37% 219.33 228.91 -4.19% 307.81 366.93 -16.11% 365.58 360.19 1.50%
EBIDTM 16.98% 26.60% 17.01% 20.54% 21.52% 26.03% 23.67% 26.46%
Other Income 22.11 21.02 5.19% 14.54 19.92 -27.01% 12.93 15.38 -15.93% 18.08 15.45 17.02%
Interest 6.94 1.82 281.32% 3.38 1.70 98.82% 1.43 2.29 -37.55% 1.06 2.31 -54.11%
Depreciation 61.71 55.87 10.45% 60.94 52.50 16.08% 58.65 53.52 9.59% 56.96 52.12 9.29%
PBT 222.69 379.87 -41.38% 169.55 194.63 -12.89% 260.66 326.50 -20.17% 325.64 321.21 1.38%
Tax 74.26 70.77 4.93% 28.76 30.93 -7.02% 57.33 56.73 1.06% 67.91 52.59 29.13%
PAT 148.43 309.10 -51.98% 140.79 163.70 -14.00% 203.33 269.77 -24.63% 257.73 268.62 -4.05%
PATM 9.36% 19.74% 10.92% 14.69% 14.21% 19.13% 16.69% 19.74%
EPS 5.64 12.09 -53.35% 5.13 6.36 -19.34% 3.88 10.46 -62.91% 9.86 10.53 -6.36%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 5,390.04 5,366.66 5,114.11 4,337.82 3,605.66 3,193.40 3,102.21 2,843.06 3,087.84 3,234.82 2,771.24 Net Sales Growth 5.02% 4.94% 17.90% 20.31% 12.91% 2.94% 9.12% -7.93% -4.54% 16.73% Cost Of Goods Sold 1,781.49 1,540.51 1,402.41 1,292.23 1,010.36 966.04 936.63 891.24 956.40 953.85 949.52 Gross Profit 3,608.55 3,826.15 3,711.70 3,045.59 2,595.30 2,227.36 2,165.58 1,951.82 2,131.44 2,280.97 1,821.72 GP Margin 66.95% 71.29% 72.58% 70.21% 71.98% 69.75% 69.81% 68.65% 69.03% 70.51% 65.74% Total Expenditure 4,283.03 4,175.73 3,663.90 3,439.48 2,926.87 2,766.48 2,703.54 2,585.54 2,582.48 2,528.38 2,236.09 Power & Fuel Cost - 231.97 201.48 196.82 175.25 159.89 148.93 140.03 133.39 125.94 103.36 % Of Sales - 4.32% 3.94% 4.54% 4.86% 5.01% 4.80% 4.93% 4.32% 3.89% 3.73% Employee Cost - 1,089.63 948.84 870.79 752.24 712.78 674.93 603.35 541.22 477.86 376.57 % Of Sales - 20.30% 18.55% 20.07% 20.86% 22.32% 21.76% 21.22% 17.53% 14.77% 13.59% Manufacturing Exp. - 580.25 501.49 449.83 363.05 359.41 400.11 380.86 437.27 412.77 328.81 % Of Sales - 10.81% 9.81% 10.37% 10.07% 11.25% 12.90% 13.40% 14.16% 12.76% 11.87% General & Admin Exp. - 238.68 223.46 233.95 261.02 262.26 237.93 277.90 239.23 245.82 196.76 % Of Sales - 4.45% 4.37% 5.39% 7.24% 8.21% 7.67% 9.77% 7.75% 7.60% 7.10% Selling & Distn. Exp. - 398.79 323.91 355.23 317.80 275.05 281.33 226.94 248.38 234.50 213.47 % Of Sales - 7.43% 6.33% 8.19% 8.81% 8.61% 9.07% 7.98% 8.04% 7.25% 7.70% Miscellaneous Exp. - 95.90 62.31 40.63 47.15 31.05 23.68 65.22 26.59 77.64 213.47 % Of Sales - 1.79% 1.22% 0.94% 1.31% 0.97% 0.76% 2.29% 0.86% 2.40% 2.44% EBITDA 1,107.01 1,190.93 1,450.21 898.34 678.79 426.92 398.67 257.52 505.36 706.44 535.15 EBITDA Margin 20.54% 22.19% 28.36% 20.71% 18.83% 13.37% 12.85% 9.06% 16.37% 21.84% 19.31% Other Income 61.33 111.90 128.60 84.16 71.57 57.70 56.52 46.27 58.65 51.14 44.23 Interest 12.74 10.37 11.13 18.84 21.09 27.46 25.99 31.11 29.11 27.60 34.01 Depreciation 207.55 204.10 187.72 178.69 171.88 174.36 171.00 161.23 177.17 100.89 84.00 PBT 948.05 1,088.36 1,379.96 784.97 557.39 282.80 258.20 111.45 357.73 629.09 461.37 Tax 218.01 217.42 239.19 132.51 102.48 49.69 69.91 18.93 101.62 151.72 129.98 Tax Rate 23.00% 19.98% 17.33% 16.88% 18.39% 17.57% 27.08% 16.99% 28.41% 24.12% 28.17% PAT 730.04 870.94 1,140.77 652.46 454.91 233.11 188.29 92.52 256.11 477.37 331.39 PAT before Minority Interest 730.04 870.94 1,140.77 652.46 454.91 233.11 188.29 92.52 256.11 477.37 331.39 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.54% 16.23% 22.31% 15.04% 12.62% 7.30% 6.07% 3.25% 8.29% 14.76% 11.96% PAT Growth -24.88% -23.65% 74.84% 43.43% 95.15% 23.80% 103.51% -63.87% -46.35% 44.05% EPS 28.78 34.33 44.97 25.72 17.93 9.19 7.42 3.65 10.09 18.82 13.06

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 5,849.74 5,796.74 5,394.94 4,619.03 3,745.69 3,257.76 3,156.19 2,867.11 3,144.40 3,281.77 2,805.94 Net Sales Growth 7.31% 7.45% 16.80% 23.32% 14.98% 3.22% 10.08% -8.82% -4.19% 16.96% Cost Of Goods Sold 2,047.88 1,790.78 1,547.98 1,455.41 1,090.34 978.34 939.40 903.04 968.00 963.06 955.10 Gross Profit 3,801.86 4,005.96 3,846.96 3,163.62 2,655.35 2,279.42 2,216.79 1,964.07 2,176.40 2,318.71 1,850.84 GP Margin 64.99% 69.11% 71.31% 68.49% 70.89% 69.97% 70.24% 68.50% 69.22% 70.65% 65.96% Total Expenditure 4,687.79 4,539.12 3,913.71 3,728.56 3,067.42 2,815.78 2,740.77 2,593.42 2,630.33 2,569.79 2,268.34 Power & Fuel Cost - 242.12 207.10 201.22 176.50 161.92 151.00 141.67 135.94 127.91 104.79 % Of Sales - 4.18% 3.84% 4.36% 4.71% 4.97% 4.78% 4.94% 4.32% 3.90% 3.73% Employee Cost - 1,177.39 1,013.57 921.23 787.40 735.88 695.98 625.58 566.70 497.99 391.79 % Of Sales - 20.31% 18.79% 19.94% 21.02% 22.59% 22.05% 21.82% 18.02% 15.17% 13.96% Manufacturing Exp. - 610.04 524.21 471.80 374.26 366.92 404.52 387.75 439.11 415.69 331.73 % Of Sales - 10.52% 9.72% 10.21% 9.99% 11.26% 12.82% 13.52% 13.96% 12.67% 11.82% General & Admin Exp. - 261.34 242.22 249.90 271.85 268.52 246.68 245.42 246.73 255.40 205.02 % Of Sales - 4.51% 4.49% 5.41% 7.26% 8.24% 7.82% 8.56% 7.85% 7.78% 7.31% Selling & Distn. Exp. - 402.81 324.86 359.15 317.84 277.62 280.74 223.67 245.00 231.18 212.94 % Of Sales - 6.95% 6.02% 7.78% 8.49% 8.52% 8.89% 7.80% 7.79% 7.04% 7.59% Miscellaneous Exp. - 54.64 53.77 69.85 49.23 26.58 22.45 66.29 28.85 78.56 212.94 % Of Sales - 0.94% 1.00% 1.51% 1.31% 0.82% 0.71% 2.31% 0.92% 2.39% 2.39% EBITDA 1,161.95 1,257.62 1,481.23 890.47 678.27 441.98 415.42 273.69 514.07 711.98 537.60 EBITDA Margin 19.86% 21.70% 27.46% 19.28% 18.11% 13.57% 13.16% 9.55% 16.35% 21.69% 19.16% Other Income 67.66 121.72 129.19 86.50 74.66 58.08 54.76 40.77 58.69 51.97 39.88 Interest 12.81 11.20 12.27 19.77 22.24 27.57 26.91 34.56 32.13 30.23 36.48 Depreciation 238.26 232.42 209.17 210.50 182.42 177.73 172.95 163.26 179.55 103.13 86.73 PBT 978.54 1,135.72 1,388.98 746.70 548.27 294.76 270.32 116.64 361.08 630.59 454.27 Tax 228.26 224.77 240.14 135.33 104.24 51.11 67.52 20.44 101.93 152.39 129.94 Tax Rate 23.33% 19.79% 17.29% 18.12% 19.01% 17.34% 24.98% 17.52% 28.23% 24.17% 28.60% PAT 750.28 905.24 1,147.71 614.13 447.39 243.65 202.80 96.20 259.15 478.20 324.33 PAT before Minority Interest 742.40 910.95 1,148.84 611.37 444.03 243.65 202.80 96.20 259.15 478.20 324.33 Minority Interest -7.88 -5.71 -1.13 2.76 3.36 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.83% 15.62% 21.27% 13.30% 11.94% 7.48% 6.43% 3.36% 8.24% 14.57% 11.56% PAT Growth -25.80% -21.13% 86.88% 37.27% 83.62% 20.14% 110.81% -62.88% -45.81% 47.44% EPS 29.57 35.68 45.24 24.21 17.63 9.60 7.99 3.79 10.21 18.85 12.78

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 5,523.34 4,752.72 3,677.54 3,136.66 2,694.94 2,475.12 2,283.05 2,233.33 1,981.61 1,569.85 Share Capital 25.37 25.37 25.27 25.27 25.24 25.24 25.24 25.24 25.24 25.24 Total Reserves 5,497.97 4,727.35 3,640.33 3,111.39 2,669.38 2,449.88 2,257.81 2,208.09 1,956.37 1,544.61 Non-Current Liabilities 604.22 191.82 265.43 307.04 420.11 546.49 661.70 696.75 456.21 509.21 Secured Loans 395.18 9.13 64.21 133.94 234.01 347.22 433.63 447.65 292.12 366.21 Unsecured Loans 0.00 0.00 14.17 0.00 0.00 4.52 50.65 53.75 0.00 0.00 Long Term Provisions 40.98 37.29 30.98 25.28 25.88 24.55 20.22 17.91 14.49 12.21 Current Liabilities 1,339.30 1,065.59 1,241.60 1,013.84 992.65 946.34 959.88 894.16 779.55 629.69 Trade Payables 480.41 526.46 537.85 464.09 414.75 388.06 415.24 302.56 337.05 265.46 Other Current Liabilities 404.92 278.51 294.88 266.94 262.00 315.35 296.09 234.93 249.82 165.18 Short Term Borrowings 337.58 147.47 309.27 195.86 239.04 177.30 182.86 320.98 137.96 157.14 Short Term Provisions 116.39 113.15 99.60 86.95 76.86 65.63 65.69 35.69 54.72 41.91 Total Liabilities 7,466.86 6,010.13 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 3,824.24 3,217.37 2,708.75 Net Block 2,084.78 1,868.60 1,840.97 1,740.10 1,854.61 1,945.97 1,976.58 1,752.96 1,306.11 1,075.33 Gross Block 3,276.06 2,888.47 2,679.08 2,412.97 2,358.72 2,276.99 2,137.32 2,465.90 1,851.29 1,524.85 Accumulated Depreciation 1,191.28 1,019.87 838.11 672.87 504.11 331.02 160.74 712.94 545.18 449.52 Non Current Assets 3,275.94 2,732.34 2,472.46 2,171.99 2,200.54 2,256.30 2,304.86 2,230.93 1,634.73 1,323.95 Capital Work in Progress 289.04 182.00 84.19 65.96 73.23 94.87 128.93 266.95 164.90 129.17 Non Current Investment 728.21 474.01 410.47 231.86 146.28 98.01 97.43 81.86 28.75 21.79 Long Term Loans & Adv. 158.80 182.34 123.30 128.11 115.80 103.53 79.61 118.33 125.12 87.77 Other Non Current Assets 15.11 25.39 13.53 5.96 10.62 13.92 22.31 10.83 9.85 9.89 Current Assets 4,190.92 3,277.79 2,712.11 2,285.55 1,907.16 1,711.65 1,599.77 1,593.31 1,582.64 1,384.80 Current Investments 719.31 393.83 238.25 90.38 69.35 113.57 0.00 0.00 0.15 0.15 Inventories 1,750.15 1,517.09 1,266.96 1,055.55 873.17 873.54 831.93 916.98 838.30 733.34 Sundry Debtors 815.94 774.46 839.13 632.06 594.38 501.98 441.45 353.55 448.76 415.93 Cash & Bank 592.97 306.92 152.40 259.81 131.03 17.53 161.98 113.19 69.22 54.66 Other Current Assets 312.55 230.29 192.85 218.35 239.23 205.03 164.41 209.59 226.21 180.72 Short Term Loans & Adv. 57.59 55.20 22.52 29.40 13.68 15.60 19.72 37.03 53.58 40.26 Net Current Assets 2,851.62 2,212.20 1,470.51 1,271.71 914.51 765.31 639.89 699.15 803.09 755.11 Total Assets 7,466.86 6,010.13 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 3,824.24 3,217.37 2,708.75

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 5,491.97 4,701.65 3,627.48 3,122.39 2,688.57 2,455.26 2,259.19 2,208.43 1,959.66 1,553.78 Share Capital 25.37 25.37 25.27 25.27 25.24 25.24 25.24 25.24 25.24 25.24 Total Reserves 5,466.60 4,676.28 3,590.27 3,097.12 2,663.01 2,430.02 2,233.95 2,183.19 1,934.42 1,528.54 Non-Current Liabilities 602.07 189.69 290.29 313.40 419.42 548.32 662.57 699.57 459.45 509.52 Secured Loans 395.18 9.13 88.80 133.94 234.01 347.22 433.63 447.65 292.12 366.21 Unsecured Loans 0.00 0.00 14.17 6.91 0.00 4.52 50.64 55.56 1.88 0.00 Long Term Provisions 42.73 38.56 32.23 25.28 25.88 24.55 20.22 18.03 14.93 12.21 Current Liabilities 1,465.88 1,160.54 1,326.42 1,097.50 1,007.57 955.93 969.95 904.36 791.45 633.65 Trade Payables 557.70 664.86 609.85 524.32 423.47 396.54 421.11 306.59 340.99 268.37 Other Current Liabilities 420.52 204.49 304.57 274.74 266.75 316.41 297.50 236.44 250.88 166.00 Short Term Borrowings 367.81 176.61 310.95 209.69 239.04 177.30 184.85 325.35 143.94 157.14 Short Term Provisions 119.85 114.58 101.05 88.75 78.31 65.68 66.49 35.98 55.64 42.14 Total Liabilities 7,636.84 6,066.41 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 3,812.36 3,210.56 2,696.95 Net Block 2,417.52 2,072.43 2,058.73 1,940.38 1,952.96 1,983.27 2,014.18 1,800.43 1,353.59 1,104.23 Gross Block 3,758.81 3,201.39 2,985.73 2,632.86 2,464.33 2,318.22 2,176.95 2,546.33 1,932.05 1,579.07 Accumulated Depreciation 1,341.29 1,128.96 927.00 692.48 511.37 334.95 162.77 745.90 578.46 474.84 Non Current Assets 3,179.67 2,629.45 2,402.11 2,171.08 2,170.08 2,217.69 2,269.79 2,198.38 1,609.14 1,299.78 Capital Work in Progress 306.43 234.82 133.28 66.33 73.00 94.64 128.74 267.22 164.90 129.17 Non Current Investment 269.88 111.43 71.31 30.05 17.52 22.24 25.82 16.19 9.00 8.87 Long Term Loans & Adv. 168.94 184.42 124.68 128.36 115.83 103.58 78.44 103.47 71.26 47.49 Other Non Current Assets 16.90 26.35 14.11 5.96 10.77 13.96 22.61 11.07 10.39 10.02 Current Assets 4,457.17 3,436.96 2,855.71 2,377.75 1,945.48 1,741.82 1,621.92 1,613.98 1,601.42 1,397.17 Current Investments 719.31 393.83 238.25 90.38 69.35 113.57 0.00 0.00 0.15 0.15 Inventories 1,857.97 1,594.81 1,323.12 1,072.50 880.59 882.22 837.42 926.56 847.58 741.03 Sundry Debtors 910.78 811.75 895.20 681.51 602.27 500.16 445.87 353.00 449.79 417.81 Cash & Bank 640.66 365.07 180.92 282.30 150.57 35.85 175.54 124.79 76.01 58.24 Other Current Assets 328.45 234.70 195.92 221.21 242.70 210.02 163.09 209.63 227.89 179.94 Short Term Loans & Adv. 65.52 36.80 22.30 29.85 14.44 15.56 17.31 36.19 53.84 31.22 Net Current Assets 2,991.29 2,276.42 1,529.29 1,280.25 937.91 785.89 651.97 709.62 809.97 763.52 Total Assets 7,636.84 6,066.41 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 3,812.36 3,210.56 2,696.95

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 840.14 1,096.06 561.43 495.65 323.86 271.14 696.00 455.34 514.78 386.85 PBT 1,088.36 1,379.96 784.97 557.39 282.80 258.20 111.45 357.73 629.09 461.37 Adjustment 212.88 172.50 180.77 174.79 185.03 161.82 201.27 182.03 134.36 117.23 Changes in Working Capital -267.37 -214.53 -257.90 -128.87 -86.56 -94.56 412.34 -9.96 -118.48 -100.02 Cash after chg. in Working capital 1,033.87 1,337.93 707.84 603.31 381.27 325.46 725.06 529.80 644.97 478.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -193.73 -241.87 -146.41 -107.66 -57.41 -54.32 -29.06 -74.46 -130.19 -91.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -823.89 -559.56 -499.13 -122.98 -119.34 -145.55 -213.62 -685.71 -362.07 -260.92 Net Fixed Assets -494.63 -307.20 -284.34 -46.98 -60.09 -105.61 466.60 -716.66 -362.17 -275.00 Net Investments -579.68 -219.12 -326.48 -106.61 -4.05 -114.15 -15.57 -52.96 -6.96 20.86 Others 250.42 -33.24 111.69 30.61 -55.20 74.21 -664.65 83.91 7.06 -6.78 Cash from Financing Activity 426.10 -307.38 -138.67 -222.83 -130.43 -156.39 -414.16 254.99 -138.36 -80.63 Net Cash Inflow / Outflow 442.35 229.12 -76.37 149.84 74.09 -30.80 68.22 24.62 14.35 45.30 Opening Cash & Equivalents 501.19 272.07 348.44 198.60 124.51 155.31 87.09 67.46 53.11 7.81 Closing Cash & Equivalent 943.54 501.19 272.07 348.44 198.60 124.51 155.31 92.08 67.46 53.11

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 856.04 1,090.13 570.35 501.03 341.13 281.91 708.65 455.29 522.29 388.77 PBT 1,135.72 1,388.98 738.89 546.46 290.53 262.06 116.64 361.08 630.59 454.27 Adjustment 195.11 183.07 247.37 187.36 192.51 174.86 211.11 187.91 139.92 126.16 Changes in Working Capital -272.75 -236.33 -263.69 -121.97 -84.44 -103.73 410.30 -18.68 -117.72 -100.10 Cash after chg. in Working capital 1,058.08 1,335.72 722.57 611.85 398.60 333.19 738.05 530.31 652.79 480.33 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -202.04 -245.59 -152.22 -110.82 -57.47 -51.28 -29.40 -75.02 -130.50 -91.56 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -855.05 -520.69 -509.65 -165.06 -135.40 -148.82 -218.33 -676.40 -369.01 -259.87 Net Fixed Assets -494.63 -307.20 -284.34 -46.98 -60.09 -105.61 466.60 -716.66 -362.17 -275.00 Net Investments -579.68 -219.12 -326.48 -106.61 -4.05 -114.15 -15.57 -52.96 -6.96 20.86 Others 219.26 5.63 101.17 -11.47 -71.26 70.94 -669.36 93.22 0.12 -5.73 Cash from Financing Activity 426.81 -305.82 -136.54 -183.20 -130.41 -159.13 -461.51 250.54 -136.13 -82.93 Net Cash Inflow / Outflow 427.80 263.62 -75.84 152.77 75.32 -26.04 28.81 29.43 17.15 45.97 Opening Cash & Equivalents 559.01 295.39 370.92 218.15 142.83 168.87 140.06 74.25 56.69 10.72 Closing Cash & Equivalent 990.93 559.01 295.39 370.92 218.15 142.83 168.87 103.68 74.25 56.69

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 217.71 187.34 290.11 248.25 213.52 196.13 180.91 176.97 157.02 124.39 ROA 12.92% 20.38% 13.53% 10.62% 5.77% 4.78% 2.39% 7.27% 16.11% 13.15% ROE 16.95% 27.10% 19.18% 15.60% 9.02% 7.91% 4.10% 12.15% 26.88% 23.40% ROCE 19.52% 30.54% 20.84% 16.76% 9.53% 8.97% 4.52% 13.48% 27.57% 24.46% Fixed Asset Turnover 1.75 1.85 1.72 1.52 1.39 1.43 1.24 1.45 1.94 2.00 Receivable days 53.76 57.30 61.48 61.61 62.15 54.52 51.03 46.94 48.31 49.28 Inventory Days 110.43 98.87 97.05 96.88 99.02 98.55 112.26 102.68 87.80 90.97 Payable days 103.66 123.17 47.09 49.40 50.05 51.96 52.98 39.18 36.44 31.15 Cash Conversion Cycle 60.53 33.00 111.44 109.09 111.12 101.10 110.31 110.44 99.66 109.10 Total Debt/Equity 0.14 0.05 0.12 0.14 0.23 0.29 0.38 0.42 0.30 0.39 Interest Cover 105.95 124.99 42.67 27.43 11.30 10.93 4.58 13.29 23.79 14.57

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 216.47 185.32 286.15 247.12 213.02 194.55 179.02 174.99 155.28 123.12 ROA 13.30% 20.29% 12.47% 10.25% 6.03% 5.17% 2.50% 7.38% 16.19% 12.91% ROE 17.87% 27.63% 18.15% 15.28% 9.47% 8.60% 4.31% 12.43% 27.22% 23.10% ROCE 20.41% 30.92% 19.92% 16.53% 9.94% 9.44% 4.82% 13.78% 27.92% 24.38% Fixed Asset Turnover 1.68 1.75 1.65 1.48 1.37 1.43 1.23 1.42 1.89 1.95 Receivable days 53.92 57.48 61.90 62.09 61.27 53.75 50.16 46.12 47.78 49.05 Inventory Days 108.09 98.25 94.05 94.47 97.98 97.70 110.76 101.93 87.49 90.74 Payable days 111.16 136.39 49.85 51.13 50.35 52.23 52.92 39.11 36.45 31.30 Cash Conversion Cycle 50.86 19.34 106.10 105.43 108.90 99.22 108.00 108.95 98.82 108.49 Total Debt/Equity 0.14 0.05 0.13 0.15 0.23 0.29 0.38 0.42 0.31 0.40 Interest Cover 102.40 114.20 38.77 25.65 11.69 11.05 4.38 12.24 21.86 13.45

Top Investors:

dsp midcap fund

hdfc trustee company ltd - a/c hdfc mid - capopportunities fund

icici prudential multi asset fund

nippon life india trustee ltd-a/c nippon india growth fund

hdfc life insurance company limited

mirae asset emerging bluechip fund

kotak emerging equity scheme

uti flexi cap fund

axis mutual fund trustee limited a/c axis mutual fund a/c axis midcap fund

l and t mutual fund trustee ltd-l and t mid cap fund

Annual Reports:

News Update:

Ipca Laboratories - Quarterly Results
10th Aug 2022, 13:20 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback